Industry news
- Industry news
- Financings
- News
PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Company details
If you want to find out more about the company visit Pro-Dex profile.
Related reports
Related news
Latest News
- CULS Conversion and Additional Listing
- Neuronetics selected by World Economic Forum as 2011 Technology Pioneer
- Ferro Corporation Announces Expiration and Final Results of Tender Offer for its 6.50% Convertible Senior Notes Due 2013
- PharmaGap Announces Closing of First Tranche of Private Placement
- THERMOGENESIS ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE ON NASDAQ CAPITAL MARKET AUGUST 27, 2010
- Achillion Announces Private Placement of $50 Million
- THERMOGENESIS ANNOUNCES STOCKHOLDER AUTHORIZATION OF REVERSE SPLIT
- TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING
- PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010
- More news... | RSS Feed...
Most Viewed
CULS Conversion and Additional Listing
Neuronetics selected by World Economic Forum as 2011 Technology Pioneer
TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING
Achillion Announces Private Placement of $50 Million
PharmaGap Announces Closing of First Tranche of Private Placement
THERMOGENESIS ANNOUNCES STOCKHOLDER AUTHORIZATION OF REVERSE SPLIT
PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010
THERMOGENESIS ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE ON NASDAQ CAPITAL MARKET AUGUST 27, 2010
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us